Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012 (2012), Article ID 146590, 13 pages
http://dx.doi.org/10.1155/2012/146590
Review Article

Surgical Treatment of Neuroendocrine Liver Metastases

1Department of Surgical Oncology, National Cancer Centre, 11 Hospital Drive, Singapore 169610
2Department of General Surgery, Singapore General Hospital, Outram Road, Singapore 169608
3Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857

Received 15 July 2011; Accepted 12 October 2011

Academic Editor: Dermot O'Toole

Copyright © 2012 Ser Yee Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. M. Modlin, K. D. Lye, and M. Kidd, “A 5-decade analysis of 13,715 carcinoid tumors,” Cancer, vol. 97, no. 4, pp. 934–959, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Fendrich, P. Michl, N. Habbe, and D. K. Bartsch, “Liver-specific therapies for metastases of neuroendocrine pancreatic tumors,” World Journal of Hepatology, vol. 2, no. 10, pp. 367–373, 2010. View at Google Scholar
  3. J. C. Yao, M. Hassan, A. Phan et al., “One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States,” Journal of Clinical Oncology, vol. 26, no. 18, pp. 3063–3072, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. C. Yao, A. T. Phan, D. Z. Chang et al., “Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study,” Journal of Clinical Oncology, vol. 26, no. 26, pp. 4311–4318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. D. Leotlela, A. Jauch, H. Holtgreve-Grez, and R. V. Thakker, “Genetics of neuroendocrine and carcinoid tumours,” Endocrine-Related Cancer, vol. 10, no. 4, pp. 437–450, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Ihse, B. Persson, and S. Tibblin, “Neuroendocrine metastases of the liver,” World Journal of Surgery, vol. 19, no. 1, pp. 76–82, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. M. H. Kulke and R. J. Mayer, “Carcinoid tumors,” The New England Journal of Medicine, vol. 340, no. 11, pp. 858–868, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Lepage, B. Rachet, and M. P. Coleman, “Survival from malignant digestive endocrine tumors in England and Wales: a population-based study,” Gastroenterology, vol. 132, no. 3, pp. 899–904, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Mazzaferro, A. Pulvirenti, and J. Coppa, “Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?” Journal of Hepatology, vol. 47, no. 4, pp. 460–466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Öberg and B. Eriksson, “Endocrine tumours of the pancreas,” Best Practice and Research: Clinical Gastroenterology, vol. 19, no. 5, pp. 753–781, 2005. View at Publisher · View at Google Scholar
  11. T. Berge and F. Linell, “Carcinoid tumours. Frequency in a defined population during a 12 year period,” Acta Pathologica et Microbiologica Scandinavica. Section A, vol. 84, no. 4, pp. 322–330, 1976. View at Google Scholar
  12. S. Saha, S. Hoda, R. Godfrey, C. Sutherland, and K. Raybon, “Carcinoid tumors of the gastrointestinal tract: a 44-year experience,” Southern Medical Journal, vol. 82, no. 12, pp. 1501–1505, 1989. View at Google Scholar · View at Scopus
  13. F. G. Que, D. M. Nagorney, K. P. Batts, L. J. Linz, and L. K. Kvols, “Hepatic resection for metastatic neuroendocrine carcinomas,” American Journal of Surgery, vol. 169, no. 1, pp. 36–43, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Benevento, L. Boni, L. Frediani, A. Ferrari, and R. Dionigi, “Result of liver resection as treatment for metastases from noncolorectal cancer,” Journal of Surgical Oncology, vol. 74, no. 1, pp. 24–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Sarmiento, M. B. Farnell, F. G. Que, and D. M. Nagorney, “Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis,” World Journal of Surgery, vol. 26, no. 10, pp. 1267–1271, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Ahlman, G. Westberg, B. Wängberg et al., “Treatment of liver metastases of carcinoid tumors,” World Journal of Surgery, vol. 20, no. 2, pp. 196–202, 1996. View at Publisher · View at Google Scholar
  17. G. P. McEntee, D. M. Nagorney, L. K. Kvols, C. G. Moertel, and C. S. Grant, “Cytoreductive hepatic surgery for neuroendocrine tumors,” Surgery, vol. 108, no. 6, pp. 1091–1096, 1990. View at Google Scholar · View at Scopus
  18. R. B. Galland and L. H. Blumgart, “Carcinoid syndrome. Surgical management,” British Journal of Hospital Medicine, vol. 35, no. 3, pp. 166–170, 1986. View at Google Scholar · View at Scopus
  19. J. M. Sarmiento, G. Heywood, J. Rubin, D. M. Ilstrup, D. M. Nagorney, and F. G. Que, “Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival,” Journal of the American College of Surgeons, vol. 197, no. 1, pp. 29–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. C. Mayo, M. C. de Jong, M. Bloomston et al., “Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis,” Annals of Surgical Oncology, pp. 1–9, 2011. View at Publisher · View at Google Scholar
  21. K. S. Gurusamy, V. Pamecha, D. Sharma, and B. R. Davidson, “Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD007118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Frilling, J. Li, E. Malamutmann, K. W. Schmid, A. Bockisch, and C. E. Broelsch, “Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease,” British Journal of Surgery, vol. 96, no. 2, pp. 175–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. S. Chamberlain, D. Canes, K. T. Brown et al., “Hepatic neuroendocrine metastases: does intervention alter outcomes?” Journal of the American College of Surgeons, vol. 190, no. 4, pp. 432–445, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. C. B. Rosen, D. M. Nagorney, H. F. Taswell et al., “Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma,” Annals of Surgery, vol. 216, no. 4, pp. 493–505, 1992. View at Google Scholar · View at Scopus
  25. J. Scheele, R. Stangl, A. Altendorf-Hofmann, and F. P. Gall, “Indicators of prognosis after hepatic resection for colorectal secondaries,” Surgery, vol. 110, no. 1, pp. 13–29, 1991. View at Google Scholar · View at Scopus
  26. H. Chen, J. M. Hardacre, A. Uzar, J. L. Cameron, and M. A. Choti, “Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?” Journal of the American College of Surgeons, vol. 187, no. 1, pp. 88–93, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. J. G. Touzios, J. M. Kiely, S. C. Pitt et al., “Neuroendocrine hepatic metastases: does aggressive management improve survival?” Annals of Surgery, vol. 241, no. 5, pp. 776–785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. A. Norton, R. S. Warren, M. G. Kelly et al., “Aggressive surgery for metastatic liver neuroendocrine tumors,” Surgery, vol. 134, no. 6, pp. 1057–1065, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Elias, P. Lasser, M. Ducreux et al., “Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study,” Surgery, vol. 133, no. 4, pp. 375–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. G. L. Grazi, M. Cescon, F. Pierangeli et al., “Highly aggressive policy of hepatic resections for neuroendocrine liver metastases,” Hepato-Gastroenterology, vol. 47, no. 32, pp. 481–486, 2000. View at Google Scholar · View at Scopus
  31. S. Musunuru, H. Chen, S. Rajpal et al., “Metastatic neuroendocrine hepatic tumors: resection improves survival,” Archives of Surgery, vol. 141, no. 10, pp. 1000–1004, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. K. A. Yao, M. S. Talamonti, A. Nemcek et al., “Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors,” Surgery, vol. 130, no. 4, pp. 677–685, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Nave, E. Mössinger, H. Feist, H. Lang, and H. R. Raab, “Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years,” Surgery, vol. 129, no. 2, pp. 170–175, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Gomez, H. Z. Malik, A. Al-Mukthar et al., “Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumours: outcome and prognostic predictors,” HPB, vol. 9, no. 5, pp. 345–351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Dousset, O. Saint-Marc, J. Pitre, O. Soubrane, D. Houssin, and Y. Chapuis, “Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation,” World Journal of Surgery, vol. 20, no. 7, pp. 908–915, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Coppa, A. Pulvirenti, M. Schiavo et al., “Resection versus transplantation for liver metastases from neuroendocrine tumors,” Transplantation Proceedings, vol. 33, no. 1-2, pp. 1537–1539, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. M. G. House, J. L. Cameron, K. D. Lillemoe et al., “Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer,” Journal of Gastrointestinal Surgery, vol. 10, no. 1, pp. 138–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. S. K. Reddy and B. M. Clary, “Neuroendocrine liver metastases,” Surgical Clinics of North America, vol. 90, no. 4, pp. 853–861, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S. C. Mayo, M. C. de Jong, C. Pulitano et al., “Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis,” Annals of Surgical Oncology, vol. 17, no. 12, pp. 3129–3136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Clary, “Treatment of isolated neuroendocrine liver metastases,” Journal of Gastrointestinal Surgery, vol. 10, no. 3, pp. 332–334, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. S. K. Reddy, A. S. Barbas, C. E. Marroquin, M. A. Morse, P. C. Kuo, and B. M. Clary, “Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis,” Journal of the American College of Surgeons, vol. 204, no. 3, pp. 372–382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. E. S. Glazer, J. F. Tseng, W. Al-Refaie et al., “Long-term survival after surgical management of neuroendocrine hepatic metastases,” HPB, vol. 12, no. 6, pp. 427–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Hibi, T. Sano, Y. Sakamoto et al., “Surgery for hepatic neuroendocrine tumors: a single institutional experience in Japan,” Japanese Journal of Clinical Oncology, vol. 37, no. 2, pp. 102–107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Azimuddin and R. S. Chamberlain, “The surgical management of pancreatic neuroendocrine tumors,” Surgical Clinics of North America, vol. 81, no. 3, pp. 511–525, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. K. S. Gurusamy, R. Ramamoorthy, D. Sharma, and B. R. Davidson, “Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD007060, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. H. Kulke, L. L. Siu, J. E. Tepper et al., “Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting,” Journal of Clinical Oncology, vol. 29, no. 7, pp. 934–943, 2011. View at Publisher · View at Google Scholar
  47. R. J. Wong and J. J. DeCosse, “Cytoreductive surgery,” Surgery Gynecology and Obstetrics, vol. 170, no. 3, pp. 276–281, 1990. View at Google Scholar · View at Scopus
  48. F. G. Que, J. M. Sarmiento, and D. M. Nagorney, “Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors,” Cancer Control, vol. 9, no. 1, pp. 67–79, 2002. View at Google Scholar · View at Scopus
  49. M. Falconi, R. Bettini, L. Boninsegna, S. Crippa, G. Butturini, and P. Pederzoli, “Surgical strategy in the treatment of pancreatic neuroendocrine tumors,” Journal of the Pancreas, vol. 7, no. 1, pp. 150–156, 2006. View at Google Scholar · View at Scopus
  50. F. G. Que, J. M. Sarmiento, and D. M. Nagorney, “Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors,” Advances in Experimental Medicine and Biology, vol. 574, pp. 43–56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. C. G. Moertel, “Karnofsky memorial lecture. An odyssey in the land of small tumors,” Journal of Clinical Oncology, vol. 5, no. 10, pp. 1502–1522, 1987. View at Google Scholar · View at Scopus
  52. G. B. Thompson, J. A. van Heerden, C. S. Grant, J. A. Carney, and D. M. Ilstrup, “Islet cell carcinomas of the pancreas: a twenty-year experience,” Surgery, vol. 104, no. 6, pp. 1011–1017, 1988. View at Google Scholar · View at Scopus
  53. J. M. Sarmiento and F. G. Que, “Hepatic surgery for metastases from neuroendocrine tumors,” Surgical Oncology Clinics of North America, vol. 12, no. 1, pp. 231–242, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. D. A. Osborne, E. E. Zervos, J. Strosberg et al., “Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors,” Annals of Surgical Oncology, vol. 13, no. 4, pp. 572–581, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. C. G. Moertel, W. G. Sauer, M. B. Dockerty, and A. H. Baggenstoss, “Life history of the carcinoid tumor of the small intestine,” Cancer, vol. 14, pp. 901–912, 1961. View at Google Scholar
  56. M. H. Chung, J. Pisegna, M. Spirt et al., “Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver,” Surgery, vol. 130, no. 6, pp. 954–962, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. J. M. Sarmiento, F. G. Que, C. S. Grant et al., “Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach,” Surgery, vol. 132, no. 6, pp. 976–983, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. O. Søreide, T. Berstad, A. Bakka et al., “Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors,” Surgery, vol. 111, no. 1, pp. 48–54, 1992. View at Google Scholar · View at Scopus
  59. C. D. Knox, I. D. Feurer, P. E. Wise et al., “Survival and functional quality of life after resection for hepatic carcinoid metastasis,” Journal of Gastrointestinal Surgery, vol. 8, no. 6, pp. 653–659, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. L. A. Berger and D. Osborne, “Treatment of pyogenic liver abscesses by percutaneous needle aspiration,” The Lancet, vol. 1, no. 8264, pp. 132–134, 1982. View at Google Scholar · View at Scopus
  61. T. Lehnert, “Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients,” Transplantation, vol. 66, no. 10, pp. 1307–1312, 1998. View at Google Scholar · View at Scopus
  62. Y. P. Le Treut, E. Grégoire, J. Belghiti et al., “Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report,” American Journal of Transplantation, vol. 8, no. 6, pp. 1205–1213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Steinmüller, R. Kianmanesh, M. Falconi et al., “Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary,” Neuroendocrinology, vol. 87, no. 1, pp. 47–62, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. R. T. Schweizer, A. E. Alsina, R. Rosson, and S. A. Bartus, “Liver transplantation for metastatic neuroendocrine tumors,” Transplantation Proceedings, vol. 25, no. 2, p. 1973, 1993. View at Google Scholar · View at Scopus
  65. J. Eriksson, P. Stålberg, A. Nilsson et al., “Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors,” World Journal of Surgery, vol. 32, no. 5, pp. 930–938, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. M. C. Trendle, C. G. Moertel, and L. K. Kvols, “Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors,” Cancer, vol. 79, no. 4, pp. 830–834, 1997. View at Publisher · View at Google Scholar · View at Scopus
  67. E. K. Abdalla, C. C. Barnett, D. Doherty, S. A. Curley, and J. N. Vauthey, “Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization,” Archives of Surgery, vol. 137, no. 6, pp. 675–681, 2002. View at Google Scholar · View at Scopus
  68. E. K. Abdalla, A. Denys, P. Chevalier, R. A. Nemr, and J. N. Vauthey, “Total and segmental liver volume variations: implications for liver surgery,” Surgery, vol. 135, no. 4, pp. 404–410, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Truant, O. Oberlin, G. Sergent et al., “Remnant liver volume to body weight ratio ≥ 0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver,” Journal of the American College of Surgeons, vol. 204, no. 1, pp. 22–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. S. T. Fan, “Liver functional reserve estimation: state of the art and relevance for local treatments—the Eastern perspective,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 17, no. 4, pp. 380–384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. F. Manizate, S. P. Hiotis, D. Labow, S. Roayaie, and M. Schwartz, “Liver functional reserve estimation: state of the art and relevance for local treatments—the Western perspective,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 17, no. 4, pp. 385–388, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Makuuchi, T. Kosuge, T. Takayama et al., “Surgery for small liver cancers,” Seminars in Surgical Oncology, vol. 9, no. 4, pp. 298–304, 1993. View at Google Scholar
  73. K. Kubota, M. Makuuchi, K. Kusaka et al., “Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors,” Hepatology, vol. 26, no. 5, pp. 1176–1181, 1997. View at Google Scholar · View at Scopus
  74. E. Boleslawski, S. Dharancy, S. Truant, and F. R. Pruvot, “Surgical management of liver metastases from gastrointestinal endocrine tumors,” Gastroenterologie Clinique et Biologique, vol. 34, no. 4-5, pp. 274–282, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. R. Kianmanesh, O. Farges, E. K. Abdalla, A. Sauvanet, P. Ruszniewski, and J. Belghiti, “Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases,” Journal of the American College of Surgeons, vol. 197, no. 1, pp. 164–170, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. G. Ercolani, G. L. Grazi, M. Ravaioli et al., “The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy,” Annals of Surgery, vol. 239, no. 2, pp. 202–209, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Zakaria, J. H. Donohue, F. G. Que et al., “Hepatic resection for colorectal metastases: value for risk scoring systems?” Annals of Surgery, vol. 246, no. 2, pp. 183–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. K. T. E. Beckurts, A. H. Hölscher, S. Thorban, E. Bollschweiler, and J. R. Siewert, “Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases,” British Journal of Surgery, vol. 84, no. 8, pp. 1081–1084, 1997. View at Publisher · View at Google Scholar · View at Scopus
  79. C. Laurent, A. Sa Cunha, E. Rullier, D. Smith, A. Rullier, and J. Saric, “Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis,” Journal of the American College of Surgeons, vol. 198, no. 6, pp. 884–891, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. D. Jaeck, H. Nakano, P. Bachellier et al., “Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study,” Annals of Surgical Oncology, vol. 9, no. 5, pp. 430–438, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. R. P. DeMatteo, C. Palese, W. R. Jarnagin, R. L. Sun, L. H. Blumgart, and Y. Fong, “Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases,” Journal of Gastrointestinal Surgery, vol. 4, no. 2, pp. 178–184, 2000. View at Google Scholar · View at Scopus
  82. T. M. Pawlik, C. R. Scoggins, D. Zorzi et al., “Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases,” Annals of Surgery, vol. 241, no. 5, pp. 715–724, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. Z. Z. R. Hamady, I. C. Cameron, J. Wyatt, R. K. Prasad, G. J. Toogood, and J. P. A. Lodge, “Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule,” European Journal of Surgical Oncology, vol. 32, no. 5, pp. 557–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Figueras, F. Burdio, E. Ramos et al., “Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections,” Annals of Oncology, vol. 18, no. 7, pp. 1190–1195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Bodingbauer, D. Tamandl, K. Schmid, C. Plank, W. Schima, and T. Gruenberger, “Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases,” British Journal of Surgery, vol. 94, no. 9, pp. 1133–1138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. D. Elias, S. Bonnet, C. Honoré et al., “Comparison between the minimum margin defined on preoperative imaging and the final surgical margin after hepatectomy for cancer: how to manage it?” Annals of Surgical Oncology, vol. 15, no. 3, pp. 777–781, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. G. Torzilli, D. Del Fabbro, A. Palmisano et al., “Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases,” Journal of Gastrointestinal Surgery, vol. 9, no. 8, pp. 1148–1154, 2005. View at Publisher · View at Google Scholar
  88. D. Zorzi, J. T. Mullen, E. K. Abdalla et al., “Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases,” Journal of Gastrointestinal Surgery, vol. 10, no. 1, pp. 86–94, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. U. Sarpel, A. S. Bonavia, A. Grucela, S. Roayaie, M. E. Schwartz, and D. M. Labow, “Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis?” Annals of Surgical Oncology, vol. 16, no. 2, pp. 379–384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. R. J. B. Finch, H. Z. Malik, Z. Z. R. Hamady et al., “Effect of type of resection on outcome of hepatic resection for colorectal metastases,” British Journal of Surgery, vol. 94, no. 10, pp. 1242–1248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. E. K. Abdalla, R. Adam, A. J. Bilchik, D. Jaeck, J. N. Vauthey, and D. Mahvi, “Improving resectability of hepatic colorectal metastases: expert consensus statement,” Annals of Surgical Oncology, vol. 13, no. 10, pp. 1271–1280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. T. Wakai, Y. Shirai, J. Sakata et al., “Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis,” Annals of Surgical Oncology, vol. 15, no. 9, pp. 2472–2481, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. R. J. de Haas, D. A. Wicherts, E. Flores, D. Azoulay, D. Castaing, and R. Adam, “R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?” Annals of Surgery, vol. 248, no. 4, pp. 626–636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. C. Are, M. Gonen, K. Zazzali et al., “The impact of margins on outcome after hepatic resection for colorectal metastasis,” Annals of Surgery, vol. 246, no. 2, pp. 295–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. K. Shirabe, K. Takenaka, T. Gion et al., “Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin,” British Journal of Surgery, vol. 84, no. 8, pp. 1077–1080, 1997. View at Publisher · View at Google Scholar · View at Scopus
  96. S. Agrawal and J. Belghiti, “Oncologic resection for malignant tumors of the liver,” Annals of Surgery, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. W. R. Jarnagin, M. Gonen, Y. Fong et al., “Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade,” Annals of Surgery, vol. 236, no. 4, pp. 397–407, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. R. L. Jamison, J. H. Donohue, D. M. Nagorney, C. B. Rosen, W. S. Harmsen, and D. M. Ilstrup, “Hepatic resection for metastatic colorectal cancer results in cure for some patients,” Archives of Surgery, vol. 132, no. 5, pp. 505–511, 1997. View at Google Scholar · View at Scopus
  99. M. L. McDonald, D. M. Nagorney, H. M. Connolly, R. A. Nishimura, and H. V. Schaff, “Carcinoid heart disease and carcinoid syndrome: successful surgical treatment,” Annals of Thoracic Surgery, vol. 67, no. 2, pp. 537–539, 1999. View at Publisher · View at Google Scholar · View at Scopus
  100. A. W. Hemming, A. I. Reed, R. J. Howard et al., “Preoperative portal vein embolization for extended hepatectomy,” Annals of Surgery, vol. 237, no. 5, pp. 686–693, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. H. C. Weber, D. J. Venzon, J. T. Lin et al., “Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study,” Gastroenterology, vol. 108, no. 6, pp. 1637–1649, 1995. View at Publisher · View at Google Scholar · View at Scopus
  102. P. Hellman, T. Lundström, U. Öhrvall et al., “Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases,” World Journal of Surgery, vol. 26, no. 8, pp. 991–997, 2002. View at Publisher · View at Google Scholar
  103. D. Jaeck, E. Oussoultzoglou, P. Bachellier et al., “Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery,” World Journal of Surgery, vol. 25, no. 6, pp. 689–692, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. C. H. C. Dejong, R. W. Parks, E. Currie, J. Piris, D. N. Redhead, and O. J. Garden, “Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience,” Journal of the Royal College of Surgeons of Edinburgh, vol. 47, no. 2, pp. 495–499, 2002. View at Google Scholar · View at Scopus
  105. C. S. Landry, C. R. Scoggins, K. M. Mcmasters, and R. C. G. Martin, “Management of hepatic metastasis of gastrointestinal carcinoid tumors,” Journal of Surgical Oncology, vol. 97, no. 3, pp. 253–258, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. A. J. Chambers, J. L. Pasieka, E. Dixon, and O. Rorstad, “The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors,” Surgery, vol. 144, no. 4, pp. 645–653, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. A. Ahmed, G. Turner, B. King et al., “Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study,” Endocrine-Related Cancer, vol. 16, no. 3, pp. 885–894, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. J. Strosberg, N. Gardner, and L. Kvols, “Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut,” Neuroendocrinology, vol. 89, no. 4, pp. 471–476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. J. P. Boudreaux, B. Putty, D. J. Frey et al., “Surgical treatment of advanced-stage carcinoid tumors: lessons learned,” Annals of Surgery, vol. 241, no. 6, pp. 839–846, 2005. View at Publisher · View at Google Scholar · View at Scopus